This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Abilitech Medical, Inc., Cardiovascular Systems, Inc.. Active years: 2015-2023.
Company Filing History:
Years Active: 2015-2023
Title: Mark B Oreschnick: Innovator in Wearable Orthotics and Therapeutic Systems
Introduction
Mark B Oreschnick is a notable inventor based in Inver Grove Heights, MN (US). He has made significant contributions to the fields of wearable orthotics and therapeutic systems, holding a total of 2 patents. His innovative designs aim to improve the quality of life for users through advanced technology.
Latest Patents
Oreschnick's latest patents include an "Upper torso wearable orthotic device with dynamic leveling system." This device features multiple adjustment mechanisms that allow it to adapt to various body shapes, sizes, and augmentation needs. The orthotic device is designed to distribute weight dynamically across the user's chest, shoulders, and back, enhancing comfort and functionality. Another significant patent is for "Systems and methods for mixing therapeutic agents before and/or during administration." This invention focuses on the mixing of therapeutic agents to ensure homogeneity before localized delivery, improving the effectiveness of treatments.
Career Highlights
Throughout his career, Oreschnick has worked with reputable companies such as Cardiovascular Systems, Inc. and Abilitech Medical, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical devices and therapeutic solutions.
Collaborations
Oreschnick has collaborated with talented individuals in his field, including Victor Leo Schoenle and Cassandra Ann Piippo Svendsen. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.
Conclusion
Mark B Oreschnick is a distinguished inventor whose work in wearable orthotics and therapeutic systems has the potential to transform lives. His innovative patents and collaborations reflect his commitment to advancing medical technology.